CINCINNATI, March 7 /PRNewswire-FirstCall/ -- Kendle , a leading global full-service clinical research organization (CRO), announced today that Chairman and Chief Executive Officer Candace Kendle, PharmD, will participate in the Lehman Brothers Global Healthcare Conference March 8-10 in Miami Beach, Florida. The conference features senior executive presentations from nearly 200 companies in the biotechnology and healthcare services industries. Kendle's presentation will take place Thursday, March 9 at 3:45 p.m. Eastern Time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO)
The public is invited to listen to a live webcast of Kendle's presentation at www.kendle.com (click on the link provided in the Investor Events section) or at http://customer.talkpoint.com/LEHM002/030806a_cs/speaker.asp?entity=Kendle. An archived version can be accessed following Kendle's presentation and will be available until April 9. Slides accompanying Kendle's presentation will be available by 9 a.m. Eastern Time on March 9 at www.kendle.com in the Investor Relations section.
About Kendle
Kendle International Inc. is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share. With the expertise of our nearly 2,000 associates worldwide, Kendle has conducted clinical trials or provided regulatory, pharmacovigilance and validation services in 70 countries. Additional information and investor kits are available upon request from Kendle, 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202, or from the company's Web site at www.kendle.com.
Photo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.CONTACT: Patty Frank, Investors, +1-513-763-1992, or Lori Dorer, Media,+1-513-345-1685, both of Kendle International Inc.
